Insider NameBuy/SellCompany NameTickerAmountShares Change
Aug 17, 2021Aug 19, 2021Liu David Y
Chief Scientific Officer
SellProtagonist Therapeutics, IncPTGX$47.56$702,889-20.24%
Aug 06, 2019Aug 08, 2019Liu David Y
Chief Scientific Officer
SellProtagonist Therapeutics, IncPTGX$8.85$30,044-6.38%
Mar 01, 2019Mar 04, 2019Liu David Y
Chief Scientific Officer
SellProtagonist Therapeutics, IncPTGX$8.03$6,504-1.56%
Feb 06, 2019Feb 08, 2019Liu David Y
Chief Scientific Officer
SellProtagonist Therapeutics, IncPTGX$7.74$29,562-9.36%
Mar 12, 2018Mar 13, 2018Liu David Y
Chief Scientific Officer
SellProtagonist Therapeutics, IncPTGX$21.29$74,500-18.89%
Mar 02, 2018Mar 03, 2018Liu David Y
Chief Scientific Officer
SellProtagonist Therapeutics, IncPTGX$20$17,500-6.16%
Jan 16, 2018Jan 17, 2018Liu David Y
Chief Scientific Officer
SellProtagonist Therapeutics, IncPTGX$20$17,500-18.63%
Dec 18, 2017Dec 21, 2017Liu David Y
Chief Scientific Officer
SellProtagonist Therapeutics, IncPTGX$20$17,500-18.63%
Nov 30, 2017Dec 01, 2017Liu David Y
Chief Scientific Officer
SellProtagonist Therapeutics, IncPTGX$20$17,500-18.63%
Nov 13, 2017Nov 16, 2017Liu David Y
Chief Scientific Officer
SellProtagonist Therapeutics, IncPTGX$16.97$118,761-64.68%
Aug 28, 2017Aug 29, 2017Liu David Y
Chief Scientific Officer
SellProtagonist Therapeutics, IncPTGX$15$52,500-63.64%
Jul 10, 2017Jul 12, 2017Liu David Y
Chief Scientific Officer
SellProtagonist Therapeutics, IncPTGX$12.68$44,380-63.64%
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.